Client News
Safety 1st Partners with Allen & Gerritsen to Create “Signs of the Times” for Parents Working From Home
Allen & Gerritsen (A&G) and Safety 1st, a leading provider of child safety products, today unveiled “Signs of the Times,” a creative campaign rooted in empathy and humor that has refreshed the brand’s iconic “Baby on Board” sign […]
Home Use of GENOSYL® Delivery System (DS) to Administer GENOSYL® (nitric oxide) gas for Inhalation for the Treatment of Pulmonary Hypertension Complicated by COVID-19 Infection Published in American Journal of Respiratory and Critical Care Medicine
Clinicians report on first at-home treatment of COVID-19 patient with VERO Biotech’s GENOSYL DS, an innovative, tankless delivery system for inhaled nitric oxide. Click here to read full press release.
Atlanta-based biotech provides innovative portable inhaled nitric oxide delivery system; Company is hiring in Atlanta to meet increased demand; Makes emergency treatment protocols available to Atlanta hospitals
VERO Biotech LLC, an Atlanta, Georgia-based biotechnology company focused on saving lives, alleviating suffering, and improving the health economics of care, today announced that it is doubling down on its commitment to support the treatment of patients afflicted […]
FDA Grants VERO Biotech Expanded Access Emergency Use for the Treatment of Patients with COVID-19, with the GENOSYL® DS, the First and Only FDA-Approved Tankless System for the Delivery of Inhaled Nitric Oxide
The recently FDA-approved GENOSYL® inhaled nitric oxide may have pulmonary and antiviral benefits in treating pulmonary hypertension and acute infectious diseases associated with the novel coronavirus1. Click here for full press release
VERO Biotech Announces First Patient With COVID-19 Infection Complicating Pulmonary Hypertension Treated with GENOSYL® DS, the First and Only FDA-Approved Tankless System for the Delivery of Inhaled Nitric Oxide
Treatment informs FDA approval for emergency expanded access use for GENOSYL® inhaled nitric oxide. Click here to read full press release
MCRC Newsletters
Client News
Safety 1st Partners with Allen & Gerritsen to Create “Signs of the Times” for Parents Working From Home
Allen & Gerritsen (A&G) and Safety 1st, a leading provider of child safety products, today unveiled “Signs of the Times,” a creative campaign rooted in empathy and humor that has refreshed the brand’s iconic “Baby on Board” sign [...]
Home Use of GENOSYL® Delivery System (DS) to Administer GENOSYL® (nitric oxide) gas for Inhalation for the Treatment of Pulmonary Hypertension Complicated by COVID-19 Infection Published in American Journal of Respiratory and Critical Care Medicine
Clinicians report on first at-home treatment of COVID-19 patient with VERO Biotech’s GENOSYL DS, an innovative, tankless delivery system for inhaled nitric oxide. Click here to read full press release.
Atlanta-based biotech provides innovative portable inhaled nitric oxide delivery system; Company is hiring in Atlanta to meet increased demand; Makes emergency treatment protocols available to Atlanta hospitals
VERO Biotech LLC, an Atlanta, Georgia-based biotechnology company focused on saving lives, alleviating suffering, and improving the health economics of care, today announced that it is doubling down on its commitment to support the treatment of patients afflicted [...]
FDA Grants VERO Biotech Expanded Access Emergency Use for the Treatment of Patients with COVID-19, with the GENOSYL® DS, the First and Only FDA-Approved Tankless System for the Delivery of Inhaled Nitric Oxide
The recently FDA-approved GENOSYL® inhaled nitric oxide may have pulmonary and antiviral benefits in treating pulmonary hypertension and acute infectious diseases associated with the novel coronavirus1. Click here for full press release
VERO Biotech Announces First Patient With COVID-19 Infection Complicating Pulmonary Hypertension Treated with GENOSYL® DS, the First and Only FDA-Approved Tankless System for the Delivery of Inhaled Nitric Oxide
Treatment informs FDA approval for emergency expanded access use for GENOSYL® inhaled nitric oxide. Click here to read full press release